Status:
COMPLETED
A Novel Nomogram to Predict Severity of COVID-19
Lead Sponsor:
Xinqiao Hospital of Chongqing
Conditions:
COVID-19 Disease
Nomogram Model
Eligibility:
All Genders
18+ years
Brief Summary
Investigators use clinical data from a large sample of COVID-19 disease patients to screen out biomarkers associated with disease severity. Then, a novel nomogram model will be established to predict ...
Eligibility Criteria
Inclusion
- COVID-19 disease patients confirmed by virus nucleic acid RT-PCR and CT
Exclusion
- unconfirmed suspected cases
- Patients during pregnancy and lactation
- incomplete clinical data
- investigators considered patients ineligible for the trial
- Child patients
Key Trial Info
Start Date :
January 17 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04366024
Start Date
January 17 2020
End Date
December 31 2021
Last Update
February 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xinqiao Hospital of Chongqing
Chongqing, Chongqing Municipality, China, 400000